Becoming
Entrepreneur First '24Founded 2024 · 18 employees on LinkedIn · 3 known investors
Becoming.ai develops robotic closed-loop hardware that sustains mammalian development externally—regulating nutrients, waste, and gas exchange—paired with AI models that learn to predict how development unfolds and responds to intervention. The platform combines biology, robotics, and machine learning to make developmental processes testable and predictable, targeting research into developmental disease.
Also known as Becoming · Becoming.ai
Founders & leadership
Becoming was founded in 2024 by Divya Cohen and Jack Cohen.
Investors · 3
Company profile
researched Aug 2026Becoming (becoming.ai) describes itself as building "the foundational capability for developmental intelligence." Its stated platform has two components: robotic metabolic exchange systems—closed-loop hardware that regulates physiology in real time by delivering nutrients, removing waste and controlling gas exchange in order to sustain mammalian development outside the body—and "models for virtual organisms," dynamical AI models trained on data from that sustained, controlled development which learn how biological systems evolve and diverge under different conditions.
The company frames the problem it addresses as the developmental origin of most disease: drug-safety and intervention decisions currently rely on animal models and short-lived experimental systems that fail before longer-term development can occur, leaving long-horizon outcomes unpredictable. Becoming states that by reproducing key aspects of biological metabolic exchange under controlled conditions it sustained development further than previously possible and observed development responding predictably to its system. Its AI approach is positioned against machine-learning methods that assume fixed trajectories; instead the models are intended to learn rules governing how developmental systems change, predicting how possible futures branch and which interventions move a system from one outcome to another.
The two components are described as operating as a closed loop: sustained development generates data, models learn from that data, and model predictions guide subsequent experiments in real time. Applications the company lists are testing treatments for safety, modelling disease progression, creating personalized tissue, and supporting life from its earliest stages. Public materials referenced on the site include a white paper, a launch film, a blog, media page, and an article by Ashlee Vance. [0][1][3]
Traction
The only traction indicators in the sources are qualitative: the company states it has built the robotic metabolic exchange hardware and the associated models, and that it sustained development further than previously possible and observed predictable responses to its system. It publishes a white paper, a launch film and a blog, and references coverage by Ashlee Vance. No customers, revenue or funding figures appear in the sources. [0][1][3]
Latest developments
The website advertises a launch film, a white paper and an article by Ashlee Vance, and states the company is actively recruiting across AI, robotics and biology, directing candidates to open roles and careers@becoming.ai. Site pages carry a 2026 copyright notice. [0][1][3]
▸Full profile — market position, technology, go-to-market
Market position
The company positions its platform as an alternative to animal models and short-lived experimental systems, which it says fail before longer-term development can be observed, and contrasts its branching-trajectory models with machine-learning approaches that assume fixed trajectories. [0][1]
Becoming's stated differentiator is the pairing of externally sustained mammalian development with AI models trained on that sustained, perturbable development, enabling development to be sustained, perturbed and predicted within one closed loop rather than observed retrospectively. It claims to have sustained development further than previously possible by reproducing key aspects of biological metabolic exchange under controlled conditions. [0][1]
Technology
The technology combines closed-loop robotic hardware with dynamical AI modelling. The hardware performs robotic metabolic exchange—real-time regulation of physiology through nutrient delivery, waste removal and gas-exchange control—to sustain mammalian development externally past the point at which metabolic demand normally causes experimental systems to fail. On top of the resulting data, the company trains dynamical AI models of "virtual organisms" intended to capture branching developmental trajectories rather than a single fixed path, and to predict how interventions shift outcomes. Hardware and models are coupled in a loop in which model predictions direct the next round of experiments in real time. [0][1]
Go-to-market
Public materials do not name customers. The stated use cases point to drug safety testing, disease-progression modelling, personalized tissue creation and support of life at its earliest stages, areas associated with pharmaceutical and biomedical research. [0][1]
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsBecoming's website presents its robotic metabolic exchange hardware and virtual-organism AI models alongside a launch film, a white paper and a referenced article by Ashlee Vance.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Becomingbecoming.ai · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Becoming do?
- Becoming builds robotic systems that sustain mammalian development externally, paired with AI models that predict developmental outcomes.
- Who founded Becoming?
- Becoming was founded by Divya Cohen, Jack Cohen in 2024.
- Who are Becoming's investors?
- Becoming's investors include Entrepreneur First, Jetstream, Julian Capital.


